Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals

R. C. Petersen, G. E. Smith, R. J. Ivnik, E. G. Tangalos, D. J. Schaid, S. N. Thibodeau, E. Kokmen, S. C. Waring and L. T. Kurland
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

OBJECTIVE--The outcome of patients with mild cognitive impairment is not known, yet these patients present a difficult dilemma for the clinician. This study was designed to characterize the outcome of a group of patients with mild cognitive impairment and to determine whether the presence of the epsilon 4 allele on the apolipoprotein E gene (APOE) is a predictor of that outcome. DESIGN--A prospective, longitudinal inception cohort. SETTING--General community clinic. PARTICIPANTS--A consecutive sample of 66 patients who met criteria for a diagnosis of a mild cognitive impairment and who had at least one clinical reevaluation was identified from the Mayo Clinic Alzheimer's Disease Center/Alzheimer's Disease Patient Registry. INTERVENTIONS--We evaluated patients initially and at 12- to 18-month intervals up to 54 months using standard neurological and neuropsychological measures such as the Mini-Mental State Examination, the Dementia Rating Scale, the Wechsler Adult Intelligence Scale--Revised, the Wechsler Memory Scale--Revised, and the Free and Cued Selective Reminding Test. The APOE status of study patients was determined. MAIN OUTCOME MEASURE--The development of dementia as determined by the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition and the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria. RESULTS--Sixty-six individuals had been reevaluated once (mean of 18 months), 36 individuals twice (mean of 36 months), and 22 individuals on three occasions (mean of 54 months), with conversion rates to dementia at these intervals of 24%, 44%, and 55%, respectively. A multivariate Cox regression model demonstrated that possession of an APOE epsilon 4 allele was the strongest predictor of clinical outcome. CONCLUSIONS--These data suggest the following: (1) patients with mild cognitive impairment can be clinically defined, (2) many members of this group progress to Alzheimer's disease, and (3) APOE epsilon 4 allele status appears to be a strong predictor of clinical progression.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients
Bombois et al.
Stroke 2008;39:2046-2051.
ABSTRACT | FULL TEXT  

Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis
Anstey et al.
AJGP 2008;16:343-354.
ABSTRACT | FULL TEXT  

Effects of a Goal-Oriented Rehabilitation Program in Mild Cognitive Impairment: A Pilot Study
Londos et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;23:177-183.
ABSTRACT  

Increased CSF-BACE 1 activity is associated with ApoE-{varepsilon}4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
Ewers et al.
Brain 2008;131:1252-1258.
ABSTRACT | FULL TEXT  

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
Jack et al.
Brain 2008;131:665-680.
ABSTRACT | FULL TEXT  

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Lobar Distribution of Changes in Gray Matter and White Matter in Memory Clinic Patients: Detected Using Magnetization Transfer Imaging
van Es et al.
Am. J. Neuroradiol. 2007;28:1938-1942.
ABSTRACT | FULL TEXT  

Neurocognitive Impairment and Dementia in Mood Disorders
Pfennig et al.
J. Neuropsychiatry Clin. Neurosi. 2007;19:373-382.
ABSTRACT | FULL TEXT  

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
Boeve et al.
Brain 2007;130:2770-2788.
ABSTRACT | FULL TEXT  

Depressed Mood in Informal Caregivers of Individuals With Mild Cognitive Impairment
Lu et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;22:273-285.
ABSTRACT  

Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive Impairment
Whitwell et al.
Arch Neurol 2007;64:1130-1138.
ABSTRACT | FULL TEXT  

Conversion to Dementia From Questionable Dementia in an Ethnic Chinese Population
Liu et al.
J Geriatr Psychiatry Neurol 2007;20:76-83.
ABSTRACT  

Transitions to Mild Cognitive Impairments, Dementia, and Death: Findings from the Nun Study
Tyas et al.
Am J Epidemiol 2007;165:1231-1238.
ABSTRACT | FULL TEXT  

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment
Fleisher et al.
Neurology 2007;68:1588-1595.
ABSTRACT | FULL TEXT  

Making Sense of Mild Cognitive Impairment: A Qualitative Exploration of the Patient's Experience
Lingler et al.
Gerontologist 2006;46:791-800.
ABSTRACT | FULL TEXT  

Mortality in amnestic mild cognitive impairment: A prospective community study
Hunderfund et al.
Neurology 2006;67:1764-1768.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment Should Be Considered for DSM-V
Petersen and O'Brien
J Geriatr Psychiatry Neurol 2006;19:147-154.
ABSTRACT  

Genetics and Dementia Nosology
Blacker and Lovestone
J Geriatr Psychiatry Neurol 2006;19:186-191.
ABSTRACT  

Conversion to dementia from mild cognitive disorder: the Cache County Study.
Tschanz et al.
Neurology 2006;67:229-234.
ABSTRACT | FULL TEXT  

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha et al.
Arch Neurol 2006;63:674-681.
ABSTRACT | FULL TEXT  

Clinical trials in mild cognitive impairment: lessons for the future
Jelic et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:429-438.
ABSTRACT | FULL TEXT  

Risk factors for transitions from normal to mild cognitive impairment and dementia
Kryscio et al.
Neurology 2006;66:828-832.
ABSTRACT | FULL TEXT  

Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease
Lam et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:92-99.
ABSTRACT  

Depression, apolipoprotein e genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
Geda et al.
Arch Neurol 2006;63:435-440.
ABSTRACT | FULL TEXT  

Combination of Clinical and Neuropsychologic Information as a Better Predictor of the Progression to Alzheimer Disease in Questionable Dementia Individuals
Lee et al.
AJGP 2006;14:130-138.
ABSTRACT | FULL TEXT  

Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Steffens et al.
Arch Gen Psychiatry 2006;63:130-138.
ABSTRACT | FULL TEXT  

Mild cognitive impairment in different functional domains and incident Alzheimer's disease
Aggarwal et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1479-1484.
ABSTRACT | FULL TEXT  

Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
Drzezga et al.
JNM 2005;46:1625-1632.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen and Morris
Arch Neurol 2005;62:1160-1163.
FULL TEXT  

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen et al.
NEJM 2005;352:2379-2388.
ABSTRACT | FULL TEXT  

Predictive Utility of Apolipoprotein E Genotype for Alzheimer Disease in Outpatients With Mild Cognitive Impairment
Devanand et al.
Arch Neurol 2005;62:975-980.
ABSTRACT | FULL TEXT  

A voxel based morphometry study on mild cognitive impairment
Pennanen et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:11-14.
ABSTRACT | FULL TEXT  

MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET
Mosconi et al.
Neurology 2004;63:2332-2340.
ABSTRACT | FULL TEXT  

Neuropsychosocial Features of Very Mild Alzheimer's Disease (CDR 0.5) and Progression to Dementia in a Community: The Tajiri Project
Meguro et al.
J Geriatr Psychiatry Neurol 2004;17:183-189.
ABSTRACT  

Apolipoprotein E {epsilon}4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Hsiung et al.
CMAJ 2004;171:863-867.
ABSTRACT | FULL TEXT  

Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study
Anttila et al.
BMJ 2004;329:539.
ABSTRACT | FULL TEXT  

Mild cognitive impairment: a cross-national comparison
Arnaiz et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1275-1280.
ABSTRACT | FULL TEXT  

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
Korf et al.
Neurology 2004;63:94-100.
ABSTRACT | FULL TEXT  

Mild cognitive impairment, amnestic type: An epidemiologic study
Ganguli et al.
Neurology 2004;63:115-121.
ABSTRACT | FULL TEXT  

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman et al.
Proc. Natl. Acad. Sci. USA 2004;101:284-289.
ABSTRACT | FULL TEXT  

Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment
Tang-Wai et al.
Arch Neurol 2003;60:1777-1781.
ABSTRACT | FULL TEXT  

Intrathecal inflammation precedes development of Alzheimer's disease
Tarkowski et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1200-1205.
ABSTRACT | FULL TEXT  

Mild cognitive impairment: Directions for future research
Luis et al.
Neurology 2003;61:438-444.
ABSTRACT | FULL TEXT  

Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients
Machulda et al.
Neurology 2003;61:500-506.
ABSTRACT | FULL TEXT  

Rate of Cognitive Decline in Preclinical Alzheimer's Disease: The Role of Comorbidity
Backman et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2003;58:P228-236.
ABSTRACT | FULL TEXT  

Mild cognitive impairment in the oldest old
Boeve et al.
Neurology 2003;60:477-480.
ABSTRACT | FULL TEXT  

Vitamin E Treatment Affects the Progression of Mild Cognitive Impairment to Dementia
Brenner
Arch Neurol 2003;60:292-292.
FULL TEXT  

Biological Markers in Alzheimer Disease
Neugroschl and Davis
AJGP 2002;10:660-677.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid Tau and {beta}-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment
Riemenschneider et al.
Arch Neurol 2002;59:1729-1734.
ABSTRACT | FULL TEXT  

Rates of progression in mild cognitive impairment and early Alzheimer's disease
Storandt et al.
Neurology 2002;59:1034-1041.
ABSTRACT | FULL TEXT  

Cognitive decline in AD and mild cognitive impairment is associated with global brain damage
van der Flier et al.
Neurology 2002;59:874-879.
ABSTRACT | FULL TEXT  

The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Fillit
Arch Intern Med 2002;162:1934-1942.
ABSTRACT | FULL TEXT  

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
Buerger et al.
Neurology 2002;59:627-629.
ABSTRACT | FULL TEXT  

Apolipoprotein E {epsilon}4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease
Kivipelto et al.
ANN INTERN MED 2002;137:149-155.
ABSTRACT | FULL TEXT  

Is Mild Cognitive Impairment Prodromal for Vascular Dementia Like Alzheimer's Disease?
Meyer et al.
Stroke 2002;33:1981-1985.
ABSTRACT | FULL TEXT  

Increase of Brain Oxidative Stress in Mild Cognitive Impairment: A Possible Predictor of Alzheimer Disease
Pratico et al.
Arch Neurol 2002;59:972-976.
ABSTRACT | FULL TEXT  

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia
Jack et al.
Neurology 2002;58:750-757.
ABSTRACT | FULL TEXT  

Functional deficits in patients with mild cognitive impairment: Prediction of AD
Tabert et al.
Neurology 2002;58:758-764.
ABSTRACT | FULL TEXT  

Differential Evolution of Cognitive Impairment in Nondemented Older Persons: Results From the Kungsholmen Project
Palmer et al.
Am. J. Psychiatry 2002;159:436-442.
ABSTRACT | FULL TEXT  

Learning and Recall in Subjects at Genetic Risk for Alzheimer's Disease
Chen et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:58-63.
ABSTRACT | FULL TEXT  

Current Concepts in Mild Cognitive Impairment
Petersen et al.
Arch Neurol 2001;58:1985-1992.
ABSTRACT | FULL TEXT  

Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging
Unverzagt et al.
Neurology 2001;57:1655-1662.
ABSTRACT | FULL TEXT  

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto et al.
Neurology 2001;56:1683-1689.
ABSTRACT | FULL TEXT  

Cerebrovascular and Brain Morphologic Correlates of Mild Cognitive Impairment in the National Heart, Lung, and Blood Institute Twin Study
DeCarli et al.
Arch Neurol 2001;58:643-647.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment and Alzheimer Disease: Regional Diffusivity of Water
Kantarci et al.
Radiology 2001;219:101-107.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris et al.
Arch Neurol 2001;58:397-405.
ABSTRACT | FULL TEXT  

Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication?
Guo et al.
Am J Epidemiol 2001;153:225-231.
ABSTRACT | FULL TEXT  

Stroke and Apolipoprotein E {epsilon}4 Are Independent Risk Factors for Cognitive Decline : A Population-Based Study
Dik et al.
Stroke 2000;31:2431-2436.
ABSTRACT | FULL TEXT  

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack et al.
Neurology 2000;55:484-490.
ABSTRACT | FULL TEXT  

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study
Kantarci et al.
Neurology 2000;55:210-217.
ABSTRACT | FULL TEXT  

Is APOE-{epsilon}4 a risk factor for cognitive impairment in normal aging?
Small et al.
Neurology 2000;54:2082-2088.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment in the Population and Physical Health: Data on 1,435 Individuals Aged 75 to 95
Frisoni et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2000;55:322M-328.
ABSTRACT | FULL TEXT  

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD
Xu et al.
Neurology 2000;54:1760-1767.
ABSTRACT | FULL TEXT  

APOE-{epsilon}4 is associated with memory decline in cognitively impaired elderly
Dik et al.
Neurology 2000;54:1492-1497.
ABSTRACT | FULL TEXT  

Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study
Riley et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2000;55:69S-75.
ABSTRACT | FULL TEXT  

Vitamin E and Alzheimer disease: the basis for additional clinical trials1
Grundman
Am. J. Clin. Nutr. 2000;71:630s-636s.
ABSTRACT | FULL TEXT  

Clinical Epidemiological Quality in Molecular Genetic Research: The Need for Methodological Standards
Bogardus et al.
JAMA 1999;281:1919-1926.
ABSTRACT | FULL TEXT  

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack et al.
Neurology 1999;52:1397-1397.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen et al.
Arch Neurol 1999;56:303-308.
ABSTRACT | FULL TEXT  

Prospective Study of Risk Factors for Alzheimer's Disease: Results at 7.5 Years
Zubenko et al.
Am. J. Psychiatry 1999;156:50-57.
ABSTRACT | FULL TEXT  

Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon 4 allele
Juottonen et al.
J. Neurol. Neurosurg. Psychiatry 1998;65:322-327.
ABSTRACT | FULL TEXT  

Association Between Apolipoprotein E{epsilon}4 and the Rate of Cognitive Decline in Community-Dwelling Elderly Individuals With and Without Dementia
Jonker et al.
Arch Neurol 1998;55:1065-1069.
ABSTRACT | FULL TEXT  

Epidemiology of Dementia and Alzheimer's Disease
Hendrie
AJGP 1998;6:3S-18.
ABSTRACT | FULL TEXT  

Apolipoprotein E Genotype May Predict Alzheimer's
JWatch Psychiatry 1995;1995:20-20.
FULL TEXT  

APOLIPOPROTEIN E GENOTYPE AS A PREDICTOR OF ALZHEIMER'S
JWatch General 1995;1995:2-2.
FULL TEXT